B

Bergenbio ASA
OSE:BGBIO

Watchlist Manager
Bergenbio ASA
OSE:BGBIO
Watchlist
Price: 11.8 NOK -5.9% Market Closed
Market Cap: 479.2m NOK
Have any thoughts about
Bergenbio ASA?
Write Note

Relative Value

The Relative Value of one BGBIO stock under the Base Case scenario is 0.2 NOK. Compared to the current market price of 11.8 NOK, Bergenbio ASA is Overvalued by 98%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

BGBIO Relative Value
Base Case
0.2 NOK
Overvaluation 98%
Relative Value
Price
B
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
93
vs Industry
5
Median 3Y
313 872
Median 5Y
1 047 336.9
Industry
7.7
Forward
4 572.8
vs History
vs Industry
Median 3Y
-416.6
Median 5Y
-3 370.6
Industry
22.7
Forward
-2.1
vs History
vs Industry
Median 3Y
-421.8
Median 5Y
-3 466.2
Industry
21.6
vs History
vs Industry
Median 3Y
-421.8
Median 5Y
-3 453.2
Industry
25.2
vs History
95
vs Industry
16
Median 3Y
2 496.4
Median 5Y
2 817.3
Industry
2.5
vs History
96
vs Industry
4
Median 3Y
313 686
Median 5Y
1 046 960.3
Industry
7.7
Forward
2 875.3
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
9
vs History
vs Industry
Median 3Y
-408.2
Median 5Y
-3 378.9
Industry
4.2
Forward
-1.6
vs History
vs Industry
Median 3Y
-407.4
Median 5Y
-3 364.8
Industry
4.1
Forward
-1.6
vs History
vs Industry
Median 3Y
-421.6
Median 5Y
-3 464.6
Industry
5.7
vs History
vs Industry
Median 3Y
-421.6
Median 5Y
-3 461.7
Industry
3.6
vs History
15
vs Industry
3
Median 3Y
-4 382.3
Median 5Y
-60 525.1
Industry
4.6

Multiples Across Competitors

BGBIO Competitors Multiples
Bergenbio ASA Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
NO
Bergenbio ASA
OSE:BGBIO
471m NOK 904 -3.1 -1.8 -1.8
FR
Pharnext SCA
OTC:PNEXF
6T USD 37 797 580.3 -179 646.3 -218 147.8 -215 658.5
US
Abbvie Inc
NYSE:ABBV
320.2B USD 5.8 63.3 15.6 24.1
US
Amgen Inc
NASDAQ:AMGN
151.1B USD 4.6 35.4 16.8 31.9
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
119.5B USD 11.2 -249 24.8 26.1
US
Gilead Sciences Inc
NASDAQ:GILD
114.4B USD 4 908.1 10.1 10.1
US
Epizyme Inc
F:EPE
94.1B EUR 1 863.9 -475.6 -517.9 -504.1
AU
CSL Ltd
ASX:CSL
135.7B AUD 5.9 33.2 20.5 25.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
82.8B USD 6 17.9 16.2 18.1
US
Seagen Inc
F:SGT
39.3B EUR 18 -55.1 -59.2 -53.4
NL
argenx SE
XBRU:ARGX
34.8B EUR 18.6 -130.8 -106.2 -77.4
P/E Multiple
Earnings Growth
NO
B
Bergenbio ASA
OSE:BGBIO
Average P/E: 211.6
Negative Multiple: -3.1
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -179 646.3 N/A
US
Abbvie Inc
NYSE:ABBV
63.3
412%
US
Amgen Inc
NASDAQ:AMGN
35.4
73%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -249
42%
US
Gilead Sciences Inc
NASDAQ:GILD
908.1
75%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -475.6 N/A
AU
CSL Ltd
ASX:CSL
33.2
65%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.9
43%
US
S
Seagen Inc
F:SGT
Negative Multiple: -55.1 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -130.8 N/A
EV/EBITDA Multiple
EBITDA Growth
NO
B
Bergenbio ASA
OSE:BGBIO
Average EV/EBITDA: 17.3
Negative Multiple: -1.8
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -218 147.8 N/A
US
Abbvie Inc
NYSE:ABBV
15.6
29%
US
Amgen Inc
NASDAQ:AMGN
16.8
62%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24.8
43%
US
Gilead Sciences Inc
NASDAQ:GILD
10.1
16%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -517.9 N/A
AU
CSL Ltd
ASX:CSL
20.5
42%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.2
35%
US
S
Seagen Inc
F:SGT
Negative Multiple: -59.2 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -106.2 N/A
EV/EBIT Multiple
EBIT Growth
NO
B
Bergenbio ASA
OSE:BGBIO
Average EV/EBIT: 22.6
Negative Multiple: -1.8
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -215 658.5 N/A
US
Abbvie Inc
NYSE:ABBV
24.1
88%
US
Amgen Inc
NASDAQ:AMGN
31.9
93%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
26.1
44%
US
Gilead Sciences Inc
NASDAQ:GILD
10.1
29%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -504.1 N/A
AU
CSL Ltd
ASX:CSL
25.5
55%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18.1
54%
US
S
Seagen Inc
F:SGT
Negative Multiple: -53.4 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -77.4 N/A

See Also

Discover More
Back to Top